photo
Speaker

Greg Bosch, MBA

CHIEF EXECUTIVE OFFICER, GEISTLICH PHARMA NORTH AMERICA, INC
Princeton, New Jersey, United States
Greg Bosch is the CEO of Geistlich Pharma North America, based in Princeton, NJ. As CEO, he has established Geistlich as the market leader in biomaterials/regenerative medicine in dentistry and also heads up Geistlich’s oncology program. Prior to Geistlich, he led PuriCore for 8 years taking them from a private venture-backed operation through a successful IPO on the London FTSE in 2006 (for which Greg was recognized as the Life Science CEO of the year in Philadelphia). Greg began his career at American Hospital Supply/Baxter International where he held leadership roles of increasing responsibilities over 19 years, including General Manager of the BioSurgery business which he grew to a $225 million business in 5 years.

Greg has has global leadership experience in sales, marketing, R&D, operations, and mergers and acquisitions. Greg earned a degree in Public Policy from Duke University and an MBA focused in Finance from DePaul University’s Kellstadt Graduate School of Business.
Speaking In
[Available On-Demand]
Geistlich Pharma, a family-owned Swiss company, is a world leader in the field of biomaterials and…